BR0309684A - O tratamento de dor com ifendropil - Google Patents

O tratamento de dor com ifendropil

Info

Publication number
BR0309684A
BR0309684A BR0309684-0A BR0309684A BR0309684A BR 0309684 A BR0309684 A BR 0309684A BR 0309684 A BR0309684 A BR 0309684A BR 0309684 A BR0309684 A BR 0309684A
Authority
BR
Brazil
Prior art keywords
pain
treatment
ifendropil
ifenprodil
avoids
Prior art date
Application number
BR0309684-0A
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Andrew Douglas Baxter
Alan Rothaul
Michael Harvey Lyne
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of BR0309684A publication Critical patent/BR0309684A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"O TRATAMENTO DE DOR COM IFENDROPIL". Ifenprodil é útil para o tratamento de dor, por exemplo, em administração intranasal ou por outra rota que evite o metabolismo de primeira passagem.
BR0309684-0A 2002-05-03 2003-05-06 O tratamento de dor com ifendropil BR0309684A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210264.8A GB0210264D0 (en) 2002-05-03 2002-05-03 The treatment of pain and migraine headache
PCT/GB2003/001906 WO2003092689A1 (en) 2002-05-03 2003-05-06 The treatment of pain with ifendropil

Publications (1)

Publication Number Publication Date
BR0309684A true BR0309684A (pt) 2005-03-01

Family

ID=9936088

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309684-0A BR0309684A (pt) 2002-05-03 2003-05-06 O tratamento de dor com ifendropil

Country Status (14)

Country Link
US (1) US20050222205A1 (pt)
EP (1) EP1501510A1 (pt)
JP (1) JP2005529139A (pt)
CN (1) CN1649589A (pt)
AU (1) AU2003229977A1 (pt)
BR (1) BR0309684A (pt)
CA (1) CA2485115A1 (pt)
GB (1) GB0210264D0 (pt)
IL (1) IL164951A0 (pt)
MX (1) MXPA04010658A (pt)
NO (1) NO20044769L (pt)
PL (1) PL372534A1 (pt)
WO (1) WO2003092689A1 (pt)
ZA (1) ZA200408778B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007509115A (ja) * 2003-10-21 2007-04-12 ソセイ・アール・アンド・ディー・リミテッド オピエートの増強のための非オピエートの使用
EP1675590A1 (en) * 2003-10-21 2006-07-05 Arakis Ltd. The use of ifenprodil in the treatment of pain
EP1725226A2 (en) * 2004-03-17 2006-11-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
GB0509719D0 (en) * 2005-05-12 2005-06-22 Arakis Ltd Sublingual composition
CN102133198B (zh) * 2011-03-09 2012-02-08 北京四环科宝制药有限公司 一种酒石酸艾芬地尔冻干粉针剂及其制备方法
CA3155464A1 (en) * 2019-10-28 2021-05-06 Mark Williams Use of glutamate 2b receptor antagonists and sigma receptor agonsists as antitussives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
FR2722989B1 (fr) * 1994-07-29 1997-05-30 Synthelabo Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
MXPA01012879A (es) * 1999-06-16 2003-06-24 Nastech Pharm Co Formulaciones farmaceuticas y metodos que comprenden morfina intranasal.
DK1307194T4 (da) * 2000-07-31 2011-07-18 Nycomed Danmark Aps Fentanylpræparat til nasal administration

Also Published As

Publication number Publication date
CN1649589A (zh) 2005-08-03
AU2003229977A1 (en) 2003-11-17
MXPA04010658A (es) 2005-07-01
NO20044769L (no) 2004-11-18
EP1501510A1 (en) 2005-02-02
IL164951A0 (en) 2005-12-18
JP2005529139A (ja) 2005-09-29
ZA200408778B (en) 2005-11-15
PL372534A1 (en) 2005-07-25
CA2485115A1 (en) 2003-11-13
US20050222205A1 (en) 2005-10-06
WO2003092689A1 (en) 2003-11-13
GB0210264D0 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
MXPA03007140A (es) Derivados de carbolina.
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
ATE408601T1 (de) Fredericamycin-derivate
ECSP066365A (es) Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk
BRPI0410503B8 (pt) composição tópica e uso da composição
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
CY1109309T1 (el) Παραγωγα γλυκοπυρανοσυλοξυπυραζολης και χρηση αυτων σε φαρμακευτικα σκευασματα
DE69905170T2 (de) Thiazolopyrimidinderivate
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BRPI0510947A (pt) tratamento de doença respiratória
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
MXPA03007142A (es) Derivados de carbolina.
PT1117403E (pt) Antagonistas de mglurs para o tratamento da dor e ansiedade
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
ITMI20020773A0 (it) Farmaci per il trattamento dell'artrite
BR0309684A (pt) O tratamento de dor com ifendropil
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.